Summary Statement: ADARC Program Project on HIV/SIV Vaccine Development

PAGE 1 P01 A143042-01 18 SEP Ho, David D. stage of HIV vaccine research. A large number of permutations and combinations can be imagined with all of the various parameters that are going to be investigated - MVA versus DNA vaccines, a number of different B cell antigens (loop-deleted, deglycosylated, pseudovirions, CD4-env complexes, monomeric versus oligomeric envelope), and several different adjuvants. Consequently, the investigators plan to initially study immunogenicity in guinea pigs. They further acknowledge that guinea pigs are not non-human primates, and so the immunogenicity experiments that they plan to perform in order to evaluate the antigen candidates may not be exactly translatable. Although the applicants state that details of the immunization and challenge experiments go be carried out in the last few years of the 5-year period are somewhat sketchy, the details that they do provide suggest that the investigators will not be testing for the development of any mucosal immune response which will probably be critical for a potential HIVvaccine. The envelope complementation assay is neither referred to nor described. There is no detail given on how the DNA vaccines will be produced. Even though the investigators have outstanding qualifications to conduct the research, because of the existing flaws, the enthusiasm for this project is relatively low at the very good range. The facilities are outstanding. The budget could not be determined. Human Subjects: code 10 Gender and Minority Representation: not applicable Animal WNelfare: code 30 Budget: The budget, as presented, cannot be evaluated. IRG Action: This Jtreceived a priority score in the good range with a numerical value o 254. Administrative Note: The budget, as written, is incomplete and lack details. Therefore, the committee has recommended that a detailed budget be resubmitted by the applicants. CORE A: Molecular Virology Core (Drs. D. Ho and C. Cheng-Mayer) Critique: The comments below represent essentially unedited comments from the reviewers of this application. They are included to indicate the range of comments made during the discussion, and may not reflect the final thinking of the committee. The RESUME and OVERALL CRITIQUE sections above summarize the final opinion of the committee after the discussion. Continued

/ 30

Actions

file_download Download Options Download this page PDF - Pages 1- Image - Page 18 Plain Text - Page 18

About this Item

Title
Summary Statement: ADARC Program Project on HIV/SIV Vaccine Development
Author
Schultz, Alan M.
Canvas
Page 18
Publication
1998-01-12
Subject terms
proposals
Item type:
proposals

Technical Details

Link to this Item
https://name.umdl.umich.edu/5571095.0421.017
Link to this scan
https://quod.lib.umich.edu/c/cohenaids/5571095.0421.017/18

Rights and Permissions

The University of Michigan Library provides access to these materials for educational and research purposes, with permission from their copyright holder(s). If you decide to use any of these materials, you are responsible for making your own legal assessment and securing any necessary permission.

Manifest
https://quod.lib.umich.edu/cgi/t/text/api/manifest/cohenaids:5571095.0421.017

Cite this Item

Full citation
"Summary Statement: ADARC Program Project on HIV/SIV Vaccine Development." In the digital collection Jon Cohen AIDS Research Collection. https://name.umdl.umich.edu/5571095.0421.017. University of Michigan Library Digital Collections. Accessed May 11, 2025.
Do you have questions about this content? Need to report a problem? Please contact us.

Downloading...

Download PDF Cancel